china l carnitine factory L-Carnitine Tablets Dietary Supplement Manufacturer OEM&ODM Service manufacturers and suppliers China High Quality Silica Factory

Shift work, risk factors and cardiovascular disease

Introduction Deep brain stimulation (DBS) of the subthalamic nucleus (STN) is the first-line surgical treatment for Parkinson's disease (PD), it can effectively improve Parkinson's disease patients' motor and non-motor symptoms ( The success of DBS is critically dependent on delivering the appropriate dose of stimulation at the best location within the target region ( In addition to improving the clinical symptoms of patients, STN-DBS has the effect of reducing dopamine drug use ( In the present study, we included 123 patients treated with STN-DBS and compared early drug reduction (drug reduction at the initial programming after surgery) and late drug reduction (reduction of drug after 36 months after surgery) differences in motor and mental symptoms, with the goal of providing clinical evidence support for drug adjustment after DBS and reducing the number of programming trial and error

One of the preferred delivery systems to avoid first pass effect is a transdermal delivery system

especially certain ROS-induced cardiovascular complications may result as a consequence of such therapies